Request an invite

Spherox

spheroids of autologous matrix-associated chondrocytes
cell therapyAutologous chondrocyte spheroidsSpherical aggregates of ex vivo expanded autologous chondrocytes with own extracellular matrixCartilage defects of the femoral condyle and patella of knee
Species
MousePigOther
Longest study
39 wk
Genotox
Not conducted Not conducted
Carcinogenicity
Not conducted Not conducted
Repro
Not conducted Not conducted
First dose
Not conducted Not stated publicly

Speciesopen answer page →

Species
Immunodeficient (SCID/NSG) mice, Goettingen minipig, Merino sheep; no conventional tox
“Comparative analyses of chondrocytes from different species showed that only a limited number of animals including Göttinger mini-pig and Merino sheep were capable of producing stable spheroids.”
✓ VerifiedEMA assessment report, p. 29Source ↗
Why that species
Only minipig and Merino sheep chondrocytes form stable spheroids; large orthotopic joint models
“These species were then selected for proof-of-concept studies.”
✓ VerifiedEMA assessment report, p. 29Source ↗
Surrogate molecule
Yes: autologous porcine and ovine spheroids produced analogously to Spherox; human spheroids in immunodeficient mice
“In these studies, either human Spheroxs or autologous spheroids produced analogously to human Spheroxs were used.”
✓ VerifiedEMA assessment report, p. 32Source ↗

Study lengthopen answer page →

Longest pivotal study
39 weeks
“The long term effects of the Spherox product cannot be fully evaluated from the in vivo data as the GLP compliant sheep study of 9 months duration failed due to loss of Spherox implants.”
✓ VerifiedEMA assessment report, p. 35Source ↗
Pivotal GLP studies
GLP Merino sheep 6/9-month implantation (failed, implant lost); GLP NSG mouse 6-month biodistribution/tumourigenicity; minipig 2-month
“study Merino sheep was designed to evaluate local and systemic toxicity during 6 months of implantation of autologous spheroids in a femoral condyle defect.”
✓ VerifiedEMA assessment report, p. 32Source ↗
Route in tox
Subcutaneous (mice); knee joint implantation/injection (minipig, sheep)
“In the in vivo studies, a single dose of spheroids was either injected or implanted into a knee joint or administered subcutaneously in the back of the animal.”
✓ VerifiedEMA assessment report, p. 32Source ↗

Skipped studiesopen answer page →

Genotoxicity
Not conducted (per cell-based product guideline)
“No genotoxicity, conventional carcinogenicity and reproductive- and developmental toxicity studies were performed”
✓ VerifiedEMA assessment report, p. 32Source ↗
Carcinogenicity
Not conducted (conventional); 6-month GLP mouse tumourigenicity part and in vitro senescence studies
“No genotoxicity, conventional carcinogenicity and reproductive- and developmental toxicity studies were performed”
✓ VerifiedEMA assessment report, p. 32Source ↗
Reproductive & developmental
Not conducted; autologous cells with local action and limited biodistribution
“Reproductive and developmental toxicity studies were not conducted.”
✓ VerifiedEMA assessment report, p. 34Source ↗
Safety pharmacology
Not evaluated; autologous cells implanted locally, no secreted substances affecting vital organs
“Safety pharmacology was not evaluated with Spherox.”
✓ VerifiedEMA assessment report, p. 31Source ↗

First doseopen answer page →

First-in-human starting dose
Not stated in public reviews
NOAEL / key findings
No NOAEL; no treatment-related adverse effects or signs of general/local toxicity in any study
“There were no indications of treatment related adverse effects and the implant was well tolerated.”
✓ VerifiedEMA assessment report, p. 32Source ↗

Risksopen answer page →

Immune & cytokine safety
No immunogenicity studies; enlarged popliteal lymph nodes in 2 sheep with allogeneic cells, possible immune response
“It should be noted that poplietal lymph nodes (lymph nodes draining the knee joint) of two of the animals were enlarged.”
✓ VerifiedEMA assessment report, p. 32Source ↗
Biodistribution & persistence
GLP NSG mouse study: no significant systemic distribution or tumour/ectopic tissue; sheep: spheroids retained in joint
“There were no indications of significant systemic distribution of the cells, or were there any indications of tumour or ectopic tissue formation after 6 months in the tumourigenicity part of this study.”
✓ VerifiedEMA assessment report, p. 31Source ↗
Modality-specific risk
Migration/infiltration into subchondral bone, genetic instability with passaging, tumourigenicity
“migration might also be a potential safety issue if the cells should have a capacity to infiltrate e.g. subchondral bone when implanted in full thickness cartilage defects”
✓ VerifiedEMA assessment report, p. 30Source ↗

Similar precedents